Dianomi Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Dianomi Therapeutics's estimated annual revenue is currently $1.9M per year.
- Dianomi Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Dianomi Therapeutics has 12 Employees.
- Dianomi Therapeutics grew their employee count by 33% last year.
Dianomi Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO, Co-Founder | Reveal Email/Phone |
2 | CSO, Co-Founder | Reveal Email/Phone |
3 | COO & GC, Co-Founder | Reveal Email/Phone |
4 | Controller | Reveal Email/Phone |
5 | Senior Scientist | Reveal Email/Phone |
Dianomi Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.8M | 18 | 20% | N/A | N/A |
#2 | $1.9M | 12 | 33% | N/A | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $5.2M | 67 | 0% | $45.5M | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $1.6M | 10 | 0% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $13.5M | 87 | -17% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is Dianomi Therapeutics?
Dianomi Therapeutics is a development stage biopharmaceutical company focused on improving the delivery and efficacy of large and small molecules in the treatment of inflammatory diseases. With an initial focus on osteoarthritis and rheumatoid arthritis, we are working to enhance the safety, efficacy, and duration of effect of therapeutic agents by incorporating them with our proprietary mineral coated microparticle system (MCM).
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.9M | 12 | -8% | N/A |
#2 | $3M | 12 | N/A | N/A |
#3 | N/A | 12 | 50% | N/A |
#4 | $1M | 12 | 9% | N/A |
#5 | $1.3M | 12 | 9% | N/A |